Canadian Sec - Delayed Quote CAD
Telescope Innovations Corp. (TELI.CN)
At close: November 1 at 1:41 PM EDT
Breakdown
TTM
8/31/2023
8/31/2022
8/31/2021
12/31/2020
Total Revenue
3,899.0260
2,824.0100
595.3980
--
--
Cost of Revenue
--
3.5000
930.1480
15.6470
--
Gross Profit
--
2,820.5100
-334.7500
-15.6470
--
Operating Expense
4,869.8470
3,542.2480
5,422.1500
4,007.9640
140.0570
Operating Income
-974.3210
-721.7380
-5,756.9000
-4,023.6110
-140.0570
Net Non Operating Interest Income Expense
--
--
--
--
-2.4350
Other Income Expense
139.7200
3.6440
9.8730
-1.7080
-2.1600
Pretax Income
-1,053.5330
-718.0940
-5,747.0270
-4,025.3190
-144.6520
Net Income Common Stockholders
-1,053.5330
-718.0940
-5,747.0270
-4,025.3190
-144.6520
Diluted NI Available to Com Stockholders
-1,053.5330
-718.0940
-5,747.0270
-4,025.3190
-144.6520
Basic EPS
-0.02
-0.01
-0.12
-0.08
-0.00
Diluted EPS
-0.02
-0.01
-0.12
-0.08
-0.00
Basic Average Shares
54,350.7040
52,716.4060
48,424.4260
47,786.0700
47,786.0700
Diluted Average Shares
54,350.7040
52,716.4060
48,424.4260
47,786.0700
47,786.0700
Rent Expense Supplemental
32.1260
132.9850
111.5080
4.9000
--
Total Expenses
4,873.3470
3,545.7480
6,352.2980
4,023.6110
140.0570
Net Income from Continuing & Discontinued Operation
-1,053.5330
-718.0940
-5,747.0270
-4,025.3190
-144.6520
Normalized Income
-1,193.2530
-721.7380
-5,756.9000
-4,023.6110
-142.4920
Interest Expense
--
--
--
--
2.4350
Net Interest Income
--
--
--
--
-2.4350
EBIT
-838.2450
-721.7380
-5,756.9000
-4,023.6110
-142.2170
EBITDA
-436.2240
-418.1400
-5,480.5600
-4,023.6110
-142.2170
Reconciled Cost of Revenue
--
3.5000
930.1480
15.6470
--
Reconciled Depreciation
402.0210
303.5980
276.3400
--
--
Net Income from Continuing Operation Net Minority Interest
-1,053.5330
-718.0940
-5,747.0270
-4,025.3190
-144.6520
Total Unusual Items Excluding Goodwill
139.7200
3.6440
9.8730
-1.7080
-2.1600
Total Unusual Items
139.7200
3.6440
9.8730
-1.7080
-2.1600
Normalized EBITDA
-575.9440
-421.7840
-5,490.4330
-4,021.9030
-140.0570
12/31/2020 - 10/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IOT.V Innovotech Inc.
0.1300
0.00%
BLAB.CN Britannia Life Sciences Inc.
0.0400
-20.00%
CVALF Covalon Technologies Ltd.
2.4500
-0.81%
MBX.TO Microbix Biosystems Inc.
0.3200
0.00%
NBTX Nanobiotix S.A.
4.4000
+5.77%
MSCL.TO Satellos Bioscience Inc.
0.8300
-1.19%
IMRN Immuron Limited
1.9518
+1.66%
ATXS Astria Therapeutics, Inc.
11.32
+1.25%
COV.V Covalon Technologies Ltd.
3.4400
+1.18%
TH.TO Theratechnologies Inc.
1.6800
-0.59%